Alnylam Pharmaceuticals (ALNY) total assets

Total assets · fiscal 2025
$4.97B

Alnylam Pharmaceuticals (ALNY) had total assets of $4.97B at the end of fiscal 2025 (December 31, 2025). That is 17.1% higher than the $4.24B of fiscal 2024. Figures as of 18 Nov 2026, 07:44 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$4.97B
Change on fiscal 2024
+17.1%
Growth, 5 years
+7.8% a year
Growth, 10 years
+13.6% a year
Highest on record
$4.97Bfiscal 2025
Lowest on record
$281.92Mfiscal 2011
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Alnylam Pharmaceuticals total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 7.8% a year; over ten years the rate was 13.6% a year. Across the 17 fiscal years on record (2009–2025), the highest was $4.97B in fiscal 2025 and the lowest $281.92M in fiscal 2011.

History · 17 fiscal years

Total assets by fiscal year

Alnylam Pharmaceuticals total assets, year by year

Alnylam Pharmaceuticals (ALNY) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$4.97B 17.1% up
2024$4.24B 10.7% up
2023$3.83B 8.0% up
2022$3.55B 2.7% down
2021$3.64B 6.9% up
2020$3.41B 42.2% up
2019$2.40B 52.1% up
2018$1.57B 21.1% down
2017$1.99B 58.0% up
2016$1.26B 8.9% down
2015$1.39B 28.4% up
2014$1.08B 156.7% up
2013$420.53M 46.3% up
2012$287.52M 2.0% up
2011$281.92M 28.3% down
2010$393.27M 18.3% down
2009$481.39M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Alnylam Pharmaceuticals and comparable companies
CompanyTotal assetsFiscal year
Tenet Healthcare THC$29.68B2025
BioNTech BNTX€21.99B2025
Guardant Health GH$2.01B2025
Alnylam Pharmaceuticals ALNY$4.97B2025
Zimmer Biomet Holdings ZBH$23.09B2025
Medpace Holdings MEDP$1.98B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ALNY

Alnylam Pharmaceuticals, figure by figure

Alnylam Pharmaceuticals (ALNY) overview: price, valuation and scorecardAll health care companies by market value

Alnylam Pharmaceuticals total assets: questions and answers

How large are Alnylam Pharmaceuticals's total assets?

Alnylam Pharmaceuticals (ALNY) had total assets of $4.97B at the end of fiscal 2025 (December 31, 2025). That is 17.1% higher than the $4.24B of fiscal 2024.

What is the growth rate of Alnylam Pharmaceuticals's total assets?

Over the five fiscal years to 2025 total assets grew at a compound 7.8% a year; over ten years the rate was 13.6% a year.

What are the highest and lowest total assets figures on record for Alnylam Pharmaceuticals?

Across the 17 fiscal years on record (2009–2025), the highest was $4.97B in fiscal 2025 and the lowest $281.92M in fiscal 2011.

How is Alnylam Pharmaceuticals's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Alnylam Pharmaceuticals (ALNY) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/ALNY/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.